Trial intelligence / Profile preview

Switching Schizophrenia Patients to Aripiprazole

NCT00545467Phase 4Completed

Sponsor
National Taiwan University Hospital
Start
Aug 2007
Primary completion
Jun 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of aripiprazole in schizophrenia, schizoaffective disorder, sponsored by National Taiwan University Hospital. Started Aug 2007; status: completed.

02

Drugs

aripiprazole
03

Conditions

schizophreniaschizoaffective disorder

Beyond the preview

Go deeper on NCT00545467.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00545467.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call